(Q61975079)
Statements
A Single Center, Multiple-dose, Non-randomized, Dose Adjustment, Open-Label Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Tolerability of Oshadi Icp in Patients With Type 1 Diabetes Mellitus -A Phase II Clinical Study (English)
0 references
December 2013
0 references
February 2017
0 references
12
0 references
21 year
0 references